CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
Research and development	$ 20,379	$ 19,111
General and administrative	5,409	5,234
Restructuring charges	1,900	0
Total operating expenses	27,688	24,345
Loss from operations	(27,688)	(24,345)
Other income (expense):
Interest income	1,117	2,374
Interest expense	(1,406)	(1,325)
Other expense, net	(62)	(51)
Other (expense) income, net	(351)	998
Net loss	(28,039)	(23,347)
Other comprehensive income (loss):
Unrealized losses on available-for-sale securities	(76)	(156)
Foreign currency translation adjustment	2	10
Total other comprehensive loss	(74)	(146)
Comprehensive loss	(28,113)	(23,493)
Net Income (Loss)	$ (28,039)	$ (23,347)
Net loss per share attributable to common stockholders - basic	$ (0.44)	$ (0.38)
Net loss per share attributable to common stockholders - diluted	$ (0.44)	$ (0.38)
Weighted-average common shares outstanding basic	64,278,527	61,772,279
Weighted-average common shares outstanding diluted	64,278,527	61,772,279